We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITC icon
11651
PUT
SITE Centers
SITC
$155M
$50.6K ﹤0.01%
5,255
-4,102
-44% -$43.2K
AVNS
11652
PUT
DELISTED
Avanos Medical
AVNS
$50.5K ﹤0.01%
2,500
+2,300
+1,150% +$52.1K
RELX icon
11653
CALL
RELX
RELX
$60B
$50.5K ﹤0.01%
+1,500
New +$49.5K
RDVY icon
11654
CALL
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
$50.5K ﹤0.01%
+1,100
New +$52.6K
SB icon
11655
PUT
Safe Bulkers
SB
$789M
$50.5K ﹤0.01%
15,600
-53,000
-77% -$171K
STVN icon
11656
CALL
Stevanato
STVN
$5.75B
$50.5K ﹤0.01%
1,700
+1,200
+240% +$37.6K
BDTX icon
11657
CALL
Black Diamond Therapeutics
BDTX
$116M
$50.5K ﹤0.01%
17,600
-92,600
-84% -$341K
TROO icon
11658
PUT
TROOPS Inc
TROO
$243M
$50.5K ﹤0.01%
12,200
PSTX
11659
CALL
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$50.5K ﹤0.01%
21,200
-26,700
-56% -$56K
OMFL icon
11660
CALL
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.88B
$50.4K ﹤0.01%
1,100
-100
-8% -$4.85K
SRRK icon
11661
CALL
Scholar Rock
SRRK
$6.4B
$50.4K ﹤0.01%
+7,100
New +$47.7K
FTK icon
11662
Flotek Industries
FTK
$1.3B
$50.4K ﹤0.01%
11,370
-9,819
-46% -$46.6K
HTOO icon
11663
CALL
Fusion Fuel Green
HTOO
$16.8M
$50.3K ﹤0.01%
1,569
+55
+4% +$3.47K
FNV icon
11664
Franco-Nevada
FNV
$45.2B
$50.3K ﹤0.01%
377
-22,088
-98% -$3.12M
ANGI icon
11665
CALL
Angi Inc
ANGI
$191M
$50.3K ﹤0.01%
2,540
-890
-26% -$25.5K
DIV icon
11666
CALL
Global X SuperDividend US ETF
DIV
$786M
$50.2K ﹤0.01%
3,100
-2,000
-39% -$33.6K
SWAN icon
11667
CALL
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$162M
$50.1K ﹤0.01%
2,100
-6,600
-76% -$167K
LBTYK icon
11668
CALL
Liberty Global Class C
LBTYK
$3.49B
$50.1K ﹤0.01%
2,700
-1,300
-33% -$25K
ALCYW
11669
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$50.1K ﹤0.01%
+292,842
New +$50.7K
IWC icon
11670
CALL
iShares Micro-Cap ETF
IWC
$1.52B
$50K ﹤0.01%
500
-6,700
-93% -$724K
RARE icon
11671
Ultragenyx Pharmaceutical
RARE
$2.61B
$49.9K ﹤0.01%
1,401
-275,282
-99% -$10.9M
FHLTU
11672
DELISTED
Future Health ESG Corp. Unit
FHLTU
$49.9K ﹤0.01%
107,378
-49
-0% -$503
MMI icon
11673
PUT
Marcus & Millichap
MMI
$1.2B
$49.9K ﹤0.01%
1,700
-10,500
-86% -$352K
PFBC icon
11674
PUT
Preferred Bank
PFBC
$1.28B
$49.8K ﹤0.01%
800
+400
+100% +$25K
RCKTW icon
11675
Rocket Pharmaceuticals Warrant
RCKTW
$117K
$49.6K ﹤0.01%
324,849
-27,965
-8% -$4.41K

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.